Most sold healthcare stocks in Q3 2020
See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2020, measured as net reductions in reported share positions from Q2 2020 into Q3 2020. Notable reductions at the top of this list include AKEBIA THERAPEUTICS INC (AKBA), GRIFOLS SA-ADR (GRFS), ASTRAZENECA PLC-SPONS ADR (AZN), BAXTER INTERNATIONAL INC (BAX). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AKBA | AKEBIA THERAPEUTICS INC | -15,005,514 | -$267.17M | 0 | 0 | 1 | 1 | 2 |
| GRFS | GRIFOLS SA-ADR | -11,952,205 | -$218.36M | 1 | 1 | 0 | 1 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -6,607,717 | -$319.74M | 1 | 2 | 2 | 0 | 5 |
| BAX | BAXTER INTERNATIONAL INC | -4,544,345 | -$374.31M | 4 | 3 | 3 | 2 | 11 |
| BHC | BAUSCH HEALTH COS INC | -4,339,263 | -$152.72M | 2 | 1 | 1 | 0 | 6 |
| NVST | ENVISTA HOLDINGS CORP | -3,779,784 | -$54.65M | 0 | 1 | 1 | 1 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -2,684,624 | -$287.28M | 2 | 2 | 2 | 0 | 8 |
| DVA | DAVITA INC | -2,634,273 | $27.71M | 1 | 0 | 3 | 1 | 5 |
| INVA | INNOVIVA INC | -2,190,494 | -$60.26M | 0 | 0 | 1 | 1 | 1 |
| HCA | HCA HEALTHCARE INC | -2,097,242 | -$63.71M | 1 | 1 | 3 | 2 | 5 |
| ALGN | ALIGN TECHNOLOGY INC | -1,824,679 | -$171.73M | 1 | 1 | 7 | 2 | 10 |
| SDGR | SCHRODINGER INC | -1,633,954 | -$395.16M | 0 | 2 | 1 | 0 | 3 |
| OSUR | ORASURE TECHNOLOGIES INC | -1,536,140 | -$16.60M | 0 | 0 | 1 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | -1,506,906 | -$40.97M | 1 | 0 | 3 | 0 | 4 |
| INSM | INSMED INC | -1,227,400 | -$33.80M | 0 | 0 | 0 | 1 | 0 |
| AMRN | AMARIN CORP PLC -ADR | -1,209,313 | -$15.58M | 1 | 0 | 1 | 1 | 2 |
| MCRB | SERES THERAPEUTICS INC | -1,202,401 | $292.65M | 0 | 0 | 2 | 0 | 2 |
| LAB | STANDARD BIOTOOLS INC | -1,157,800 | $2.91M | 0 | 0 | 1 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | -1,148,441 | -$37.66M | 2 | 1 | 6 | 0 | 10 |
| CVS | CVS HEALTH CORP | -1,110,676 | -$170.61M | 4 | 10 | 4 | 1 | 19 |
| ELAN | ELANCO ANIMAL HEALTH INC | -1,065,948 | $5.94M | 0 | 2 | 1 | 0 | 3 |
| TGTX | TG THERAPEUTICS INC | -1,056,800 | -$19.87M | 0 | 0 | 1 | 0 | 1 |
| AMGN | AMGEN INC | -1,052,006 | -$221.17M | 3 | 4 | 5 | 1 | 13 |
| AUPH | AURINIA PHARMACEUTICALS INC | -1,026,303 | -$17.17M | 0 | 1 | 1 | 1 | 2 |
| HUM | HUMANA INC | -1,002,127 | -$288.63M | 1 | 0 | 3 | 2 | 4 |
| XRAY | DENTSPLY SIRONA INC | -993,302 | -$47.41M | 1 | 3 | 3 | 0 | 7 |
| LLY | ELI LILLY & CO | -926,001 | -$61.80M | 3 | 2 | 5 | 1 | 10 |
| VERU | VERU INC | -907,900 | -$3.35M | 0 | 0 | 1 | 0 | 1 |
| DHR | DANAHER CORP | -836,748 | $240.74M | 4 | 1 | 6 | 1 | 14 |
| IQV | IQVIA HOLDINGS INC | -803,539 | -$83.39M | 1 | 0 | 2 | 2 | 4 |
| THC | TENET HEALTHCARE CORP | -624,200 | -$11.16M | 0 | 0 | 1 | 0 | 1 |
| OVID | OVID THERAPEUTICS INC | -624,109 | -$4.60M | 0 | 0 | 0 | 1 | 0 |
| ARDX | ARDELYX INC | -621,520 | -$6.08M | 0 | 0 | 1 | 0 | 1 |
| VXRT | VAXART INC | -616,328 | -$5.46M | 0 | 0 | 0 | 1 | 0 |
| ABT | ABBOTT LABORATORIES | -583,738 | $413.37M | 1 | 4 | 6 | 1 | 13 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -573,239 | $73.62M | 3 | 1 | 1 | 0 | 6 |
| GMED | GLOBUS MEDICAL INC - A | -564,892 | -$26.69M | 1 | 0 | 1 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | -539,800 | -$6.60M | 0 | 0 | 1 | 0 | 1 |
| DXCM | DEXCOM INC | -500,515 | -$144.05M | 1 | 1 | 3 | 1 | 5 |
| HSIC | HENRY SCHEIN INC | -468,187 | -$26.77M | 1 | 0 | 3 | 1 | 5 |
| ARAY | ACCURAY INC | -463,308 | $624.00K | 0 | 0 | 1 | 0 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | -461,418 | -$77.76M | 1 | 0 | 2 | 1 | 3 |
| VRTX | VERTEX PHARMACEUTICALS INC | -444,447 | -$228.53M | 2 | 2 | 1 | 1 | 5 |
| CRL | CHARLES RIVER LABORATORIES | -439,466 | -$13.06M | 1 | 0 | 2 | 0 | 3 |
| COR | CENCORA INC | -435,839 | -$48.35M | 1 | 1 | 1 | 2 | 3 |
| PGEN | PRECIGEN INC | -418,451 | -$13.35M | 0 | 0 | 1 | 2 | 1 |
| ZTS | ZOETIS INC | -414,314 | $405.75M | 2 | 3 | 4 | 1 | 10 |
| BRKR | BRUKER CORP | -397,900 | -$16.43M | 0 | 0 | 1 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -396,100 | -$5.30M | 0 | 0 | 1 | 0 | 1 |
| SNN | SMITH & NEPHEW PLC -SPON ADR | -394,200 | -$14.88M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q3 2020
What are the most sold Healthcare stocks in Q3 2020?
The most sold healthcare stocks in Q3 2020 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2020?
Among filers in this sector, net reductions were largest in companies such as AKEBIA THERAPEUTICS INC (AKBA), GRIFOLS SA-ADR (GRFS), ASTRAZENECA PLC-SPONS ADR (AZN), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2020).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.